IDS PMA accepted
This article was originally published in The Gray Sheet
Executive Summary
Imaging Diagnostic Systems' CTLM computer tomography laser mammography imaging system PMA is deemed suitable for filing by FDA, the firm says June 18. The non-invasive device is intended as an adjunct to mammography to aid in breast cancer detection using 3-D cross-sectional images (1"The Gray Sheet" April 1, 2002, p. 28)...
You may also be interested in...
Laser Mammography PMA To Be Refiled; Dense Breast Imaging Enhanced
Imaging Diagnostic Systems plans to resubmit a premarket approval application for the CTLM computed tomographic laser breast imaging system within the next two months
Imaging Diagnostic Systems Inks Contrast Collaboration With Schering AG
Imaging Diagnostic Systems expects to complete its modular PMA submission for the computer tomography laser mammography (CTLM) imaging system this summer as Schering AG begins a separate feasibility trial of the system with a new contrast agent
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.